Celldex Therapeutics, Inc. Increase (Decrease) in Deferred Revenue
Celldex Therapeutics, Inc. (CLDX) reported Increase (Decrease) in Deferred Revenue of -$39.38 million for the 12-month period ending 2010-12-31, per its 10-K filed 2013-03-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2013-03-08
- Celldex Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2010-12-31 was -$35.98M.
- Celldex Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2010-09-30 was -$1.37M.
- Celldex Therapeutics, Inc. increase (decrease) in deferred revenue for fiscal 2010 was -$39.38M.
- Celldex Therapeutics, Inc. increase (decrease) in deferred revenue for fiscal 2009 was -$2.04M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2010-12-31 | -$35.98M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-08 | -$37.34M derived: sum of 2 quarters · filed 2013-03-08 | -$39.38M 10-K · filed 2013-03-08 | |
| 2010-09-30 | -$1.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | -$3.41M 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | -$2.04M 10-Q · filed 2011-08-04 | |||
| 2009-12-31 | -$2.04M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |